HIV and coronary artery calcium score: Comparison of the Hawaii Aging with HIV Cardiovascular Study and Multi-Ethnic Study of Atherosclerosis (MESA) cohorts

HIV Clinical Trials

Volumn 16, Issue 4, 2015, Pages 130-138

  Chow, Dominic ^a   Young, Rebekah ^b   Valcour, Nicole ^a   Kronmal, Richard A ^b   Lum, Corey J ^a   Parikh, Nisha I ^c   Tracy, Russell P ^d   Budoff, Matthew ^e   Shikuma, Cecilia M ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Antiviral therapy; Coronary artery calcium; Framingham Risk Score; MESA

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM; CHOLESTEROL; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY CALCIUM SCORE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FRAMINGHAM RISK SCORE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SMOKING; UNITED STATES; ATHEROSCLEROSIS; CALCINOSIS; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; ETHNIC GROUP; ETHNOLOGY; HAWAII; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOMARKERS; C-REACTIVE PROTEIN; CALCINOSIS; CALCIUM; COHORT STUDIES; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HAWAII; HIV INFECTIONS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREVALENCE;

EID: 84948408211     PISSN: 15284336     EISSN: 19455771     Source Type: Journal    
DOI: 10.1179/1528433614Z.0000000016     Document Type: Article

References (30)

1. Carballo D, Delhumeau C, Carballo S, Bahler C, Radovanovic D, Hirschel B. Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study. AIDS Res Ther. 2015;12:4.
2. Kingsley LA, Cuervo-Rojas J, Muñoz A, Palella FJ, Post W, Witt MD. Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: multicenter AIDS cohort study. AIDS. 2008;22:1589-1599.
3. DAD Study Group, Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte Ad, et al. Class of antiretroviral drugs and the risk of myocardial infarction. JV Engl J Med. 2007;356:1723-1735.
4. Iloeje UH, Yuan Y, L'Italien G, Mauskopf J, Holmberg SD, Moorman AC. Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients. HIV Med. 2005;6:37-44.
5. Law MG, Friis-Moller N, El-Sadr WM, Weber R, Reiss P, DArminio Monforte A. The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D study. HIV Med. 2006;7:218-230.
6. Parra S, Coll B, Aragones G, Marsillach J, Beltran R, Rull A. Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation. HIV Med. 2010;11:225-231.
7. Falcone EL, Mangili A, Skinner S, Alam A, Polak JF, Wanke CA. Framingham risk score and early markers of atherosclerosis in a cohort of adults infected with HIV. Antivir Ther. 2011;16:1-8.
8. Budoff MJ, Nasir K, McClelland RL, Detrano R, Wong N, Blumenthal RS. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009;53:345-352.
9. Shikuma CM, Seto T, Liang CY, Bennett K, DeGruttola V, Gerschenson M. Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res Hum Retroviruses. 2012;28: 793-797.
10. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871-881.
11. Carr JJ, Nelson JC, Wong ND, McNitt-Gray M, Arad Y, Jacobs DR Jr. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standarized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Disk Development in Young Adults (CARDIA) study. Radiology. 2005;234:34-43.
12. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte MJ, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
13. Park KJ, Singer W, Sletten DM, Low PA, Bharucha AE. Gastric emptying in postural tachycardia syndrome: a preliminary report. Clin Auton Res. 2013;23(4):163-167.
14. Guaraldi G, Zona S, Alexopoulos N, Orlando G, Carli F, Ligabue G. Coronary aging in HIV-infected patients. Clin Infect Dis. 2009;49:1756-1762.
15. Medina S, Wessman D, Krause D, Stephenosky J, Boswell G, Crum-Cianflone N. Coronary aging in HIV-infected patients. Clin Infect Dis. 2010;51:990.
16. Guaraldi G, Zona S, Orlando G, Carli F, Ligabue G, Fiocchi F. Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. Int J Car-diovasc Imaging. 2012;28:935-941.
17. DAgostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743-753.
18. Lumley T, Kronmal R, Ma S. Relative Risk Regression in Medical Research: Models, Contrasts, Estimators, and Algorithms. (July 2006). UW Biostatistics Working Paper Series. Working Paper 293. http://biostats.bepress.com/uwbiostat/paper293.
19. Post WS, Budoff M, Kingsley LA, Palella FJ, Witt MD, Li X. Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med. 2014;160:458-468.
20. Stein JH, Currier JS, Hsue PY. Arterial disease in patients with human immunodeficiency virus infection. JACC Cardiovasc Imaging. 2014;7:515-525.
21. Mangili A, Gerrior J, Tang AM, O-Leary DH, Polak JK, Schaefer E. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score. Clin Infect Dis. 2006; 43:1482-1489.
22. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003;107:499-511.
23. Tuomisto K, Jousilahti P, Sundvall J, Pajunen P, Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality A population-based, prospective study. Thromb Haemostasis. 2006;95:511-518.
24. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC. CD4+ count-guided interruption of antiretroviral treatment. JV Engl J Med. 2006;355:2283-2296.
25. Stein JH, Hsue PY. Inflammation, immune activation and CVD risk in individuals with HIV infection. J Am Med Assoc. 2012;308:405-406.
26. Folsom AR, Evans GW, Carr JJ, Stillman AE. Association of traditional and nontraditional cardiovascular risk factors with coronary artery calcification. Angioloj. 2004;55:613-623.
27. Lehmann N, Mohlenkamp S, Mahabadi A, Schmermund A, Roggenbuck U, Seibel R. Effect of smoking and other traditional risk factors on the onset of coronary artery calcification: results of the Heinz Nixdorf recall study. Atherosclerosis. 2014;232(2):339-345.
28. Mangili A, Polak J, Skinner SC, Gerrior J, Sheehan H, Haring-ton A. HIV infection and progression of carotid and coronary atherosclerosis: the CARE study. J Acquir Immune Defic Syndr. 2011;58:148-153.
29. Lo J, Abbara S, Shturman L, Soni A, Wei J, Rocha-Filho JA. Increased prevalence of subclinical coronary atherosclerosis detected by coronary Computed tomography angiography in HIV-infected men. AIDS. 2010;24:243-253.
30. Grunfeld C, Delaney JA, Wanke C, Currier JS, Scherzer R, Biggs ML. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 2009;23:1-9.